Di0scorides Global Holdings (DGH), is a private equity firm that invests strategically in medical cannabis and adjacent technologies. DGH’s mission is to create value and outsized investor returns by bringing new, affordable medications and treatments, that will transform and shape modern medicine, to the global market by accelerating plant-based products.

Dioscorides Global Holdings 660 Madison Avenue Suite 1215 New York, NY 10065 - info@dg-holdings.com